WallStSmart
CPIX

Cumberland Pharmaceuticals Inc

NASDAQ: CPIX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$4.53
-0.68% today

Updated 2026-06-05

Market cap
$87.50M
P/E ratio
P/S ratio
2.00x
EPS (TTM)
$-0.49
Dividend yield
52W range
$2 – $7
Volume
1.2M

Cumberland Pharmaceuticals Inc (CPIX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
Last 4 quarters
Revenue YoY growth
-22.0%
Most recent quarter
EPS YoY growth
-366.9%
Most recent quarter

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-14.4%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-24.2%
2026-03-03
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-05-05$-0.22$4.53$4.37-3.5%
2026-03-03$-0.09$4.84$3.67-24.2%
2025-11-04$-0.13$2.76$2.33-15.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$0.00$-0.22$9.13M-22.0%
2025-12-31$0.00$-0.09$13.68M+31.1%
2025-09-30$0.00$-0.13$8.29M-8.7%
2025-06-30$0.00$-0.05$10.84M+10.0%
2025-03-31$0.08$11.71M+37.8%
2024-12-31$-0.14$10.44M+11.6%
2024-09-30$-0.11$9.09M-9.9%
2024-06-30$-0.08$9.85M-9.6%
2024-03-31$-0.14$8.50M
2023-12-31$-0.44$9.35M
2023-09-30$0.02$10.09M
2023-06-30$0.16$10.89M

Frequently asked questions

Has Cumberland Pharmaceuticals Inc beaten earnings estimates?

Cumberland Pharmaceuticals Inc has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.

How does CPIX stock react to earnings?

CPIX has moved an average of -14.4% the day after earnings over its last 3 reports, finishing higher after 0 of them. Next-day moves show how the market digests results in the short term, and repeated dips on strong reports usually mean expectations were already priced in.

What is Cumberland Pharmaceuticals Inc's revenue growth rate?

Cumberland Pharmaceuticals Inc reported year-over-year revenue growth of -22.0% in its most recent quarter, with EPS up -366.9%. Reading revenue growth alongside margins shows whether that growth is translating into profit.